Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoproliferative Disorders × ibrutinib × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 42 Lymphoma, Mantle-Cell 17 Lymphoma, Follicular 12 Waldenstrom Macroglobulinemia 11 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, B-Cell 9 Lymphoma 9 Lymphoma, Non-Hodgkin 8 Leukemia 8 Recurrence 7 Multiple Myeloma 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphoid 4 Leukemia, B-Cell 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms, Plasma Cell 2 Lung Neoplasms 2 Leukemia, Prolymphocytic 2 Leukemia, Myeloid, Acute 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Chromosome 17 deletion 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Bronchiolitis Obliterans Syndrome 2 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1

Interventions

blinatumomab 4 Rituximab 3 ponatinib 2 Vorinostat 2 Vincristine 2 Prednisone 2 Ifosfamide 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Brentuximab Vedotin 2 Bortezomib 2 tetulomab tetraxetan lu-177 1 pegaspargase 1 ibritumomab tiuxetan 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 acalabrutinib 1 Methotrexate 1 Melphalan 1 Lutetium 1 KW-2478 1 Imatinib Mesylate 1 Hsp90 inhibitor KU757 1 Dexamethasone 1 Daunorubicin 1 Cytarabine 1 Carmustine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡